Hydroxyapatite nanoparticles synthesis with PAMAM-like dendrimers grown in situ on their surface for potential therapeutic use
Source abstract
Abstract
Abstract Hydroxyapatite nanoparticles are among the most promising materials, widely used to design novel platforms for treating diseases, including cancer, due to their biocompatibility and structure that enables a wide range of surface functionalization, as observed with polymers. In this work, we grew a polymeric structure, poly(amidoamine) (PAMAM-G4.0-like dendrimer), on the surface of nHAp. The resulting materials were characterized by transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and X-ray photoelectron spectroscopy (XPS) to determine their size, morphology, crystallinity, and chemical composition. In vitro cytotoxicity was evaluated through MTT assays on two breast cancer cell lines, MDA-MB-231 and SK-BR-3, and in the healthy MCF-12F breast cell line. Results demonstrated that PAMAM-G4.0-like dendrimer growth was successfully achieved on the surface of hydroxyapatite nanoparticles and that the resulting material had no toxic effects on cells, making it a suitable candidate as a biocompatible platform for the delivery of biomolecules, such as drugs or genes.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Dendrimers and Hyperbranched Polymers · biodegradable polymer synthesis and properties · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31–46. https://doi.org/10.1158/2159-8290.CD-21-105910.1158/2159-8290.CD-21-1059 ↗
2. Cancer Today. Global Cancer Observatory (n.d.) International agency for research on cancer. World Health Organization. https://gco.iarc.who.int. Accessed 3 Mar 2026
3. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, Soerjomataram I (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15–23. https://doi.org/10.1016/j.breast.2022.08.01010.1016/j.breast.2022.08.010 ↗
4. Swaminathan H, Saravanamurali K, Yadav SA (2023) Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment. Med Oncol 40:1–26. https://doi.org/10.1007/s12032-023-02111-910.1007/s12032-023-02111-9 ↗
5. Fraguas-Sanchez AI, Lozza I, Torres-Suarez AI (2022) Actively targeted nanomedicines in breast cancer: from pre-clinal investigation to clinic. Cancers (Basel) 14(5):1198. https://doi.org/10.3390/cancers1405119810.3390/cancers14051198 ↗
6. Zhang K, Zhou Y, Xiao C, Zhao W, Wu H, Tang J, Li Z, Yu S, Li X, Min L, Yu Z, Wang G, Wang L, Zhang K, Yang X, Zhu X, Tu C, Zhang X (2019) Application of hydroxyapatite nanoparticles in tumor-associated bone segmental defect. Sci Adv 5(8):eaax6946. https://doi.org/10.1126/sciadv.aax6910.1126/sciadv.aax69 ↗
7. Guo X, Xue M, Chen F, Guo Q, Zhou X, Lin H, Chen Y (2022) Local delivery and controlled release of miR-34a loaded in hydroxyapatite/mesoporous organosilica nanoparticles composite-coated implant wire to accelerate bone fracture healing. Biomaterials 280:121300. https://doi.org/10.1016/j.biomaterials.2021.12130010.1016/j.biomaterials.2021.121300 ↗
8. Maia ALC, Cavalcante CH, de Souza MGF, de Ferreira CA, Rubello D, Chondrogiannis S, Cardoso VN, Ramaldes GA, de Barros ALB, Soares DCF (2016) Hydroxyapatite nanoparticles. Nucl Med Commun 37(7):775–782. https://doi.org/10.1097/MNM.000000000000051010.1097/MNM.0000000000000510 ↗
9. Yukai S, Yuyue Q, Yongming C, Hongli L, Minglong Y (2013) The synthesis and characterization of hydroxyapatite-β-alanine modified by grafting polymerization of γ-benzyl-L-glutamate-N-carboxyanhydride. Molecules 18(11):13979–13991. https://doi.org/10.3390/molecules18111397910.3390/molecules181113979 ↗
10. Adamska K, Szubert M, Voelkel A, Okulus Z (2013) Characterisation of hydroxyapatite surface modified by poly (ethylene glycol) and poly (hydroxyethyl methacrylate) grafting. Chem Pap 67:429–436. https://doi.org/10.2478/s11696-012-0297-110.2478/s11696-012-0297-1 ↗
11. Maity S, Chatterjee A, Dey A, Dey S (2022) Functionalization of hydroxyapatite with organic molecules for biomedical applications: structural, thermal, and biological aspects. J Mater Sci Mater Med 33(3):22. https://doi.org/10.1039/D4TB00551A10.1039/D4TB00551A ↗
12. Huysal M, Şenel M (2017) Dendrimer functional hydroxyapatite nanoparticles generated by functionalization with siloxane-cored PAMAM dendrons. J Colloid Interface Sci 500:105–112. https://doi.org/10.1016/j.jcis.2017.04.00410.1016/j.jcis.2017.04.004 ↗
13. Ma C, Zhu D, Lin W, Li Y, Huang Y, Zhu H, Ye M, Wang Y, Peng L, Liu X (2022) A biodegradable amphiphilic poly(aminoester) dendrimer for safe and effective siRNA delivery. J Chem Commun 58(26):4168–4171. https://doi.org/10.1039/d1cc06655b10.1039/d1cc06655b ↗
14. Bapat RA, Dharmadhikari S, Chaubal TV, Amin MCIM, Bapat P, Gorain B, Choudhury H, Vincent C, Kesharwani P (2019) The potential of dendrimer in delivery of therapeutics for dentistry. Heliyon 5(10):e02544. https://doi.org/10.1016/j.heliyon.2019.e0254410.1016/j.heliyon.2019.e02544 ↗
15. Gautam P, Gupta AK, Sharma A, Gautam T (2013) Synthesis and analytical characterization of ester and amine terminated PAMAM dendrimers. Glob J Med Res 13:6–15
16. Vázquez-Hernández F, Mendoza-Acevedo S, Mendoza-Barrera CO, Mendoza-Álvarez J, Luna-Arias JP (2017) Antibody-coupled hydroxyapatite nanoparticles as efficient tools for labeling intracellular proteins. Mater Sci Eng C Mater Biol Appl 71:909–91810.1016/j.msec.2016.10.082 ↗
17. Hernández-Silva E, Vázquez-Hernández F, Mendoza-Acevedo S, Pérez-González M, Tomás SA, Rodríguez-Fragoso P, Mendoza-Álvarez J, Luna-Arias JP (2023) Effect of stirring rate on the size of hydroxyapatite nanoparticles synthesized by a modified heat-treated precipitation method. Process Appl Ceram 17(2):133–13910.2298/PAC2302133H ↗
18. Khodadust R, Unsoy G, Yalcın S, Gunduz G, Gunduz U (2013) PAMAM dendrimer-coated iron oxide nanoparticles: synthesis and characterization of different generations. J Nanopart Res 15(3):1–1310.1007/s11051-013-1488-6 ↗
19. Shadrack DM, Mubofu EB, Nyandoro SS (2015) Synthesis of polyamidoamine dendrimer for encapsulating tetramethylscutellarein for potential bioactivity enhancement. Int J Mol Sci 16(11):26363–26377. https://doi.org/10.3390/ijms16112595610.3390/ijms161125956 ↗
20. Rattan S, Fawcett D, Poinern G (2021) Williamson–Hall-based X-ray peak profile evaluation and nano-structural characterization of rod-shaped hydroxyapatite. AIMS Mater Sci 8(3):359–372. https://doi.org/10.3934/matersci.202102310.3934/matersci.2021023 ↗
21. Kataoka T, Liu Z, Yamada I, Tagaya M (2024) Surface functionalization of hydroxyapatite nanoparticles for biomedical applications: challenges and strategies. J Mater Chem B 12(4):855–869. https://pubs.rsc.org/en/content/articlelanding/2024/tb/d4tb00551a. Accessed 23 Mar 2026.
22. Dorofeev GA, Streletskii AN, Povstugar IV, Protasov AV, Elsukov EP (2012) Determination of nanoparticle sizes by X-ray diffraction. Colloid J 74(6):675–685. https://doi.org/10.1134/S1061933X1206005110.1134/S1061933X12060051 ↗
23. Comeau P, Willett T (2018) Impact of side chain polarity on non-stoichiometric nano-hydroxyapatite surface functionalization with amino acids. Sci Rep 8(1):12700. https://doi.org/10.1038/s41598-018-31058-510.1038/s41598-018-31058-5 ↗
24. Dorozhkin SV (2010) Bioceramics of calcium orthophosphates. Biomaterials 31(7):1465–1485. https://doi.org/10.1016/j.biomaterials.2009.11.05010.1016/j.biomaterials.2009.11.050 ↗
25. Hossain MS, Ahmed S (2023) FTIR spectrum analysis to predict the crystalline and amorphous phases of hydroxyapatite. RSC Adv 13(21):14625–14630. https://doi.org/10.1039/D3RA02580B10.1039/D3RA02580B ↗
26. Sakhno Y, Iafisco M, Jaisi D (2021) Role of maturation temperature on structural substitution of carbonate in hydroxyapatite nanoparticles. JOM 73:1044–1052. https://doi.org/10.1007/s11837-021-04587-010.1007/s11837-021-04587-0 ↗
27. Smith BC (2020) Organic nitrogen compounds, VII: amides—the rest of the story. Spectroscopy 35(1):10–15
28. Tao X, Yang Y-J, Liu S, Zheng Y-Z, Fu J, Chen J-F (2013) Poly(amidoamine) dendrimer-grafted porous hollow silica nanoparticles for enhanced intracellular photodynamic therapy. Acta Biomater 9(5):6431–6438. https://doi.org/10.1016/j.actbio.2013.01.02810.1016/j.actbio.2013.01.028 ↗
29. Khater AA, Jamil WE, Gad NA (2023) The effect of polyamidoamine dendrimer, nano-hydroxyapatite, and their combination on microhardness of demineralized enamel. Al-Azhar J Dent 10(4):94–100. https://doi.org/10.58675/2974-4164.158710.58675/2974-4164.1587 ↗
30. Xiang K, Chen L, Chen W, Yang D (2021) Remineralization of dentin induced by a compound of polyamide-amine and chlorhexidine in a resin dentin bonding microenvironment. Ann Transl Med 9(6):472. https://doi.org/10.21037/atm-21-47210.21037/atm-21-472 ↗
31. Oberbek P, Bolek T, Chlanda A, Hirano S, Kusnieruk S, Rogowska-Tylman J, Nechyporenko G, Zinchenko V, Swieszkowski W, Puzyn T (2018) Characterization and influence of hydroxyapatite nanopowders on living cells. Beilstein J Nanotechnol 9:3079–3094. https://doi.org/10.3762/bjnano.9.28610.3762/bjnano.9.286 ↗
32. Wang Z, Han T, Zhu H, Tang J, Guo Y, Jin Y, Wang Y, Chen G, Gu N, Wang C (2021) Potential osteoinductive effects of hydroxyapatite nanoparticles on mesenchymal stem cells by endothelial cell interaction. Nanoscale Res Lett 16(67):1–16. https://doi.org/10.1186/s11671-021-03522-110.1186/s11671-021-03522-1 ↗
33. Kumar A, Rai Y, Bhatt AN (2024) Anti-cancer drug-mediated increase in mitochondrial mass limits the application of metabolic viability-based MTT assay in cytotoxicity screening. Cytotechnology 76(3):301–31110.1007/s10616-024-00618-1 ↗
34. Manke A, Wang L, Rojanasakul Y (2013) Mechanisms of nanoparticle‐induced oxidative stress and toxicity. BioMed Res Int 2013(1):942916. https://doi.org/10.1155/2013/94291610.1155/2013/942916 ↗
35. Janaszewska A, Łazniewska J, Trzepiński P, Marcinkowska M, Klajnert-Maculewicz B (2019) Cytotoxicity of dendrimers. Biomolecules. https://doi.org/10.3390/biom908033010.3390/biom9080330 ↗
36. Maity T, Balachandran AK, Krishnamurthy LP, Nagar KL, Upadhyayula RS, Sengupta S, Maiti PK (2024) Data-driven approaches to predict dendrimer cytotoxicity. ACS Omega 9:24899–24906. https://doi.org/10.1021/acsomega.4c0177510.1021/acsomega.4c01775 ↗
37. Andón FT, Fadeel B (2013) Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials. Acc Chem Res 46(3):733–742. https://doi.org/10.1021/ar300020b10.1021/ar300020b ↗
38. Singh L, Jain H, Sharma P, Singh M, Ezebuiro V (2026) Functionalized hydroxyapatite nanocomposites for localized drug delivery in bone cancer. Hybrid Advances 100609. https://doi.org/10.1016/j.hybadv.2026.10060910.1016/j.hybadv.2026.100609 ↗
39. Awwad NS, Eed EM, El Askary A, Ibrahium HA, Moustapha ME, Ahmed MK (2022) Development of nanocomposite based on hydroxyapatite/hematite/graphene oxide for medical applications. J Mater Res Technol 18:4340–4352. https://doi.org/10.1016/j.jmrt.2022.03.12910.1016/j.jmrt.2022.03.129 ↗
40. Ramasamy S, Dhamecha D, Kaliyamoorthi K, Pillai AS, Alexander A, Dhanaraj P, Menon JU, Enoch IV (2021) Magnetic hydroxyapatite nanomaterial–cyclodextrin tethered polymer hybrids as anticancer drug carriers. Mater Adv 2(10):3315–332710.1039/D1MA00142F ↗